tiprankstipranks

Thomas Mccourt Insider Profile

4 Followers
Thomas Mccourt, CEO, Director at Ironwood Pharma, holds 1.15M shares in Ironwood Pharma (Ticker: IRWD), holds 0.00 shares in Acceleron Pharma (Ticker: XLRN), holds ― shares in Pliant Therapeutics (Ticker: PLRX). Most recently, Thomas Mccourt Sold ― shares of Ironwood Pharma on May 22, 2024 for an estimated value of 436.14K.
tipranks
Thomas Mccourt

Thomas Mccourt
Ironwood Pharma (IRWD)
CEO, Director

Ranked #14,573 out of 97,944 Corporate Insiders

Profitable Transactions

60%
3 out of 5 Profitable Transactions

Average Return

+23.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$8M
100.00%
0.00%
A breakdown of Thomas Mccourt's holdings

Insider Roles

Ironwood Pharma
(IRWD)
CEO, Director
Pliant Therapeutics
(PLRX)
Director
Roles that Thomas Mccourt holds in companies

Most Profitable Insider Trade

Stock:
Ironwood Pharma
(IRWD)
Rating:Informative Sell
Date:Feb 14, 2024 - Today
Return:+57.70%
The most profitable trade made by Thomas Mccourt

Thomas Mccourt's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Ironwood Pharma
May 22, 2024
CEO, Director
Informative Sell
436.14K
$7.50M
XLRN
Acceleron Pharma
Nov 22, 2021
Uninformative Sell
$0.00
Pliant Therapeutics
Director
List of latest transactions for each holding click on a transaction to see Thomas Mccourt's performance on stock

Thomas Mccourt insider profile FAQ

What is the percentage of profitable transactions made by Thomas Mccourt?
The percentage of profitable transactions made by Thomas Mccourt is 60%.
    What is the average return per transaction made by Thomas Mccourt?
    The average return per transaction made by Thomas Mccourt is 23.90%.
      What stocks does Thomas Mccourt hold?
      Thomas Mccourt holds: IRWD, XLRN, PLRX stocks.
        What was Thomas Mccourt’s latest transaction?
        Thomas Mccourt latest transaction was an Informative Sell of $436.14K.
          What was Thomas Mccourt's most profitable transaction?
          Thomas Mccourt’s most profitable transaction was an Informative Sell of IRWD stock on February 14, 2024. The return on the trade was 57.70%.
            What is Thomas Mccourt's role in Ironwood Pharma?
            Thomas Mccourt's role in Ironwood Pharma is CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.